Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828438 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00828438 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 40 participants.
The verdict
NCT00828438, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
Interventions
- DRUG Lorcaserin 10mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828438
The ClinicalTrials.gov registry entry for NCT00828438 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lorcaserin 10mg is the first listed.
NCT00828438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828438 about?
NCT00828438 is a clinical study titled "Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment". The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
What is the current status of trial NCT00828438?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2008-10. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00828438?
The interventions under investigation include: Lorcaserin 10mg (DRUG).
Who is sponsoring clinical trial NCT00828438?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.